Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
pharmaceutical_companies:pfizer [2022/09/29 19:35]
pamela [Academic Partners UCSF]
pharmaceutical_companies:pfizer [2023/01/10 17:37] (current)
liam [Payments to Individuals]
Line 356: Line 356:
 | [[:Dawn Bowdish]]  | Research Award  | Unknown  | Funds for pneumonia research from [[:Ontario Lung Association]] and [[Pfizer]], and ASPIRE-Pfizer New Investigator Award.((Bowdish, D. M. E. (2013, February 11). //Dr. Dawn Bowdish receives a research award from the Ontario Lung Association and Pfizer Canada (and gets to attend a swanky event to receive it!).// Bowdish Lab. Retrieved December 1, 2021, from https://archive.ph/AQqx1)) ((Bowdish, D. M. E. (2011, July 3). //Dawn wins ASPIRE-Pfizer New Investigator Award.// Bowdish Lab. Retrieved December 1, 2021, from https://archive.ph/Dvre1))  | | [[:Dawn Bowdish]]  | Research Award  | Unknown  | Funds for pneumonia research from [[:Ontario Lung Association]] and [[Pfizer]], and ASPIRE-Pfizer New Investigator Award.((Bowdish, D. M. E. (2013, February 11). //Dr. Dawn Bowdish receives a research award from the Ontario Lung Association and Pfizer Canada (and gets to attend a swanky event to receive it!).// Bowdish Lab. Retrieved December 1, 2021, from https://archive.ph/AQqx1)) ((Bowdish, D. M. E. (2011, July 3). //Dawn wins ASPIRE-Pfizer New Investigator Award.// Bowdish Lab. Retrieved December 1, 2021, from https://archive.ph/Dvre1))  |
 | [[:Richard Choi]]  | Speakers Bureau/Honoraria/Consulting  | Unknown  | Disclosed during CardioVascUpdate presentation.((Verma, S., Bucci, C., Choi, R., & Gupta, A. (2020, June 12). //Navigating Vascular Protective Strategies in HighRisk Patients During the Current Era: Practical Applications.// CardioVascUpdate. https://web.archive.org/web/20210304170904/https://cardiovascupdate.ca/files/2020/CV%20Update%20Symposium-Presentation.pdf))  | | [[:Richard Choi]]  | Speakers Bureau/Honoraria/Consulting  | Unknown  | Disclosed during CardioVascUpdate presentation.((Verma, S., Bucci, C., Choi, R., & Gupta, A. (2020, June 12). //Navigating Vascular Protective Strategies in HighRisk Patients During the Current Era: Practical Applications.// CardioVascUpdate. https://web.archive.org/web/20210304170904/https://cardiovascupdate.ca/files/2020/CV%20Update%20Symposium-Presentation.pdf))  |
 +| [[:Nigel Crawford]]  | Research  | Unknown  | "Investigator on a number of epidemiological surveillance research and vaccine safety research. Funds received by employer", [[:Murdoch Children's Research Institute]] (MCRI).((//Australian Technical Advisory Group on Immunisation - Conflict of Interest.// Australia Government Department of Health and Aged Care. Retrieved October 24, 2022, from https://web.archive.org/web/20221024032912/https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf))  |
 | [[:David Fisman]]  | Honorarium  | Unknown  | Honorarium paid for advisory board meetings regarding COVID-19 related projects.((Fisman, D. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/10/Declaration-of-Interest_Science-Table_David-Fisman2.pdf))  | [[:David Fisman]]  | Honorarium  | Unknown  | Honorarium paid for advisory board meetings regarding COVID-19 related projects.((Fisman, D. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/10/Declaration-of-Interest_Science-Table_David-Fisman2.pdf)) 
 | [[:Soren Gantt]]  | Grant  | Unknown  | Research grant paid to Gantt.((Lebatteux, D., Soudeyns, H., Boucoiran, I., Gantt, S., & Diallo, A. B. (2022). //Machine learning-based approach KEVOLVE efficiently identifies SARS-CoV-2 variant-specific genomic signatures.// bioRxiv. Preprint. https://doi.org/10.1101/2022.02.07.479343))  | | [[:Soren Gantt]]  | Grant  | Unknown  | Research grant paid to Gantt.((Lebatteux, D., Soudeyns, H., Boucoiran, I., Gantt, S., & Diallo, A. B. (2022). //Machine learning-based approach KEVOLVE efficiently identifies SARS-CoV-2 variant-specific genomic signatures.// bioRxiv. Preprint. https://doi.org/10.1101/2022.02.07.479343))  |
Line 617: Line 618:
  
 The collaboration builds upon an October 2010 agreement between CTI and UCSF in large-molecule – also called biologics – discovery, with both agreements aiming to accelerate the translation of biomedical research into new medications and therapies. ((https://web.archive.org/web/20210630074451/https://www.ucsf.edu/news/2013/05/106276/pfizers-centers-therapeutic-innovation-partners-ucsf-expand-drug-discovery)) The collaboration builds upon an October 2010 agreement between CTI and UCSF in large-molecule – also called biologics – discovery, with both agreements aiming to accelerate the translation of biomedical research into new medications and therapies. ((https://web.archive.org/web/20210630074451/https://www.ucsf.edu/news/2013/05/106276/pfizers-centers-therapeutic-innovation-partners-ucsf-expand-drug-discovery))
 +
 +==== Pfizer Recommends Hydroxychloroquine for Covid-19 ====
 +{{ :pharmaceutical_companies:pfizer_hcq_treats_covid_-_mechanism_page.png?600|}}
 +See Ashmedai article at Substack or [[:Hydroxychloroquine]] in wiki. ((https://ashmedai.substack.com/p/pfizer-still-recommends-hydroxychloroquine))
 +
 +TO give some added perspective, the FDA’s evidence that HCQ does NOT work is EXCLUSIVELY regarding hospitalized covid patients - precisely the same folks for which Pfizer is recommending HCQ!!
 +
 +Pfizer is so transcendently theophanic that its pronouncements are the embodiment of the scientific method, as we all witnessed when the CDC Director herself understood that a CNN report of Pfizer’s proclamation of its vaccine trial’s results amounted to an official communique of eternally settled Scientific fact.
 +{{ :pharmaceutical_companies:pfizer_hcq_treats_covid_text_box_large.png?400|}}
 +
 +
 +If Pfizer declares that HCQ works to treat covid - we can limit their revised catechism to late stage severe covid if you really want to be nitpicky here - then doesn’t this mean that the formerly heretical position that HCQ can treat covid is now fundamental doctrinal truth??
 +
 +Alternatively, if we can’t trust Pfizer, the oracle of science, who can we trust????
 +
 +Pfizer pdf Wayback((https://web.archive.org/web/20221213102408/https://pfizermedical.pfizerpro.com/api/vc/en/medical/assets/343db662-0565-4062-8956-00ddd5bb4fbb/COVID-19%20Antiviral%20-%202.%20Clinical%20Presentation-Proactive.pdf))
Back to top